SummitTX Capital, L.P.

Position in PAHC — Phibro Animal Health Corp

CIK 2052310 FORT WORTH, TX

Position in PAHC

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$4,174,024

+$2,852,825 QoQ

Shares Held

75,466

+113.4% QoQ

Ownership

0.186%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SummitTX Capital, L.P. holds $15,646,022 across 5 Drug Manufacturers - Specialty & Generic names.

#	Ticker	Company	Shares	Value (USD)
1	ALKS	Alkermes plc.	134,194	$7,031,765
2	AMLX	Amylyx Pharmaceuticals, Inc.	227,690	$4,089,312
3	PRGO	PERRIGO Co plc	231,555	$2,405,856
4	SUPN	Supernus Pharmaceuticals, Inc.	27,151	$1,262,793
5	PBH	Prestige Consumer Healthcare Inc.	18,115	$856,296

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,174,024	75,466	+113.4%	Shares	Sole	2026-05-15
2025-12-31	$1,321,199	35,364	—	Shares	Sole	2026-02-17
No filing history on record for this holder in this stock.